A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Giant Cell Arteritis

This study has been terminated.

( Interim analysis, infliximab did not reduce number of first relapses in GCA or cumulative glucocorticosteroid dosage )

Study NCT00076726 Information provided by Centocor, Inc.

First Received: February 2, 2004 Last Updated: April 18, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been terminated.
Study Completion Date:	July 2005
Estimated Primary Completion Date:	No date given